CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
2.830
-0.080 (-2.75%)
At close: Aug 28, 2025, 4:00 PM
2.770
-0.060 (-2.12%)
After-hours: Aug 28, 2025, 4:00 PM EDT
CollPlant Biotechnologies Employees
CollPlant Biotechnologies had 57 employees as of December 31, 2024. The number of employees decreased by 18 or -24.00% compared to the previous year.
Employees
57
Change (1Y)
-18
Growth (1Y)
-24.00%
Revenue / Employee
$42,140
Profits / Employee
-$228,123
Market Cap
35.99M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 57 | -18 | -24.00% |
Dec 31, 2023 | 75 | 2 | 2.74% |
Dec 31, 2022 | 73 | 7 | 10.61% |
Dec 31, 2021 | 66 | 14 | 26.92% |
Dec 31, 2020 | 52 | 14 | 36.84% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CLGN News
- 3 days ago - CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference - PRNewsWire
- 8 days ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 23 days ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS - PRNewsWire
- 6 weeks ago - CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations - PRNewsWire
- 2 months ago - COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES - PRNewsWire
- 3 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS - PRNewsWire
- 3 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES - PRNewsWire
- 3 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - PRNewsWire